Can pharmacogenomics help to improve therapy in patients with high-grade osteosarcoma?
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1038237
Reference15 articles.
1. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment
2. Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
3. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
4. Genome-wide study of methotrexate clearance replicates SLCO1B1
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma;Journal of Immunology Research;2022-10-08
2. An update on emerging drugs in osteosarcoma: towards tailored therapies?;Expert Opinion on Emerging Drugs;2019-07-03
3. Composite Hydrogel Embedded with Porous Microspheres for Long-Term pH-Sensitive Drug Delivery;Tissue Engineering Part A;2019-02
4. The role of the MTHFR C677T polymorphism in methotrexate-induced toxicity in pediatric osteosarcoma patients;Pharmacogenomics;2017-06
5. Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?;Future Oncology;2017-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3